Ticker Hub
SYRE — AI Analysis & Sentiment
3 recent AI-generated analyses for SYRE. Sentiment and confidence insights updated continuously.
Spyre Therapeutics Announces Completion of Enrollment in SKYWAY Basket Trial Evaluating SPY072 (anti-TL1A) in RA, PsA, and axSpA
Spyre Therapeutics has completed enrollment for its pivotal Phase 2 SKYWAY trial of SPY072, a significant de-risking event for this clinical-stage ...
Jun 3, 2026Spyre Announces Acceleration of Expected Topline Readout of SKYWAY Rheumatoid Arthritis Sub-study to Q3 2026
Spyre Therapeutics has accelerated the timeline for its SKYWAY rheumatoid arthritis sub-study data, bringing a key potential value inflection point...
Mar 16, 2026Spyre Therapeutics Reports Fourth Quarter and Full Year 2025 Financial Results and Provides Corporate Update
Spyre Therapeutics is well-capitalized with cash for its clinical pipeline through mid-2028, and is advancing critical Phase 2 trials expected to y...
Feb 19, 2026